Diakonhjemmet Hospital is the host institution for the research center. In addition, four institutions are partners - Oslo University Hospital, the University of Oslo, the Norwegian Rheumatology Association and the MAGIC Foundation.
At Diakonhjemmet Hospital, REMEDY is organized under the Department of Research and Innovation, led by Professor Espen A. Haavardsholm. The research projects at the hospital will mainly include patients from the Department of Rheumatology, Outpatient Clinic and Research and the Department of Anesthesia and Surgery. The Department of Rheumatology, Outpatient Clinic and Research is responsible for the treatment of rheumatology for the entire city of Oslo and has regional hospital responsibility for the South-Eastern Health Service. The clinic mainly treats patients with rheumatic joint diseases and osteoarthritis.
The Clinic for Anesthesia and Surgery cares for patients in need of planned and acute treatment in orthopedics, gastro- and general surgery, and has emergency services in intensive care medicine.
The main partner is the Department of Clinical Medicine, which is the largest department at the University of Oslo (UiO) and is responsible for education and research in all clinical disciplines. Several activities in REMEDY are carried out in close collaboration with UiO. UiO will host visiting professorships in the center. Through UiO, researchers will have access to core facilities such as the Bioinformatics Core Facility, Genomics Core Facility, Proteomics Core Facility, and the Norwegian Sequencing Center, as well as technological infrastructure such as the Sensitive Data Service (TSD) that will be used for collecting, storing, and analyzing data, including the use of artificial intelligence/machine learning.
Main partners at Oslo University Hospital (OUS) are the Department of Rheumatology, Skin and Infectious Diseases and the Department of Research and Innovation (Neuroclinic), which is also responsible for the Research Unit for Musculoskeletal Health (FORMI). REMEDY has close collaboration with Regional Research Support and NorCRIN. The center also has laboratory collaboration with the Radium Hospital.
The Norwegian Rheumatology Association (NRF) is one of the largest health organizations with around 30,000 members. NRF will contribute to the development of prioritized research areas and collaborate closely with the REMEDY Patient Council in connection with user participation in research in all research projects in REMEDY. NRF will also assist in the dissemination of research results in REMEDY through its social platforms and webinars.
The Magic Evidence Ecosystem Foundation will assist with knowledge summaries and updated guidelines through its partnership with BMJ Rapid recommendations.